Krech U, Wilhelm J A
J Gen Virol. 1979 Aug;44(2):281-6. doi: 10.1099/0022-1317-44-2-281.
The rubella haemagglutination inhibition (HAI) test has been modified for the detection of rubella-specific IgM. The rubella HAI test is performed in microtitre plate wells in which IgM from patients' sera has been selectively retained by anti-human IgM bound to the polystyrene surface. The test requires only anti-human IgM-coated microtitre plates, in addition to the standard rubella HAI reagents. The results obtained in this test, a solid-phase immunosorbent technique (SPIT), are in good agreement with results obtained by the sucrose density gradient centrifugation technique (DGCT). Advantages include the essentially unrestricted number of sera which can be tested daily, the availability of results within 24 h and the lack of interference by rheumatoid factor and by rubella-specific IgG.
风疹血凝抑制(HAI)试验已作改良,用于检测风疹特异性IgM。风疹HAI试验在微量滴定板孔中进行,患者血清中的IgM已被结合到聚苯乙烯表面的抗人IgM选择性保留。该试验除了标准的风疹HAI试剂外,仅需要抗人IgM包被的微量滴定板。此试验作为一种固相免疫吸附技术(SPIT)所获得的结果,与蔗糖密度梯度离心技术(DGCT)所获得的结果高度一致。优点包括每天可检测的血清数量基本不受限制、24小时内可获得结果以及不受类风湿因子和风疹特异性IgG的干扰。